📌 RBM42 Identified as a Mediator of Oncogenic mRNA Translation Specificity
🔗 Find More Research Here: pubmed.ai/?utm_source=X&utm_…
Context
- RNA-binding proteins (RBPs) are crucial for post-transcriptional gene regulation.
- Aberrant RBP activity contributes to cancer-specific translation programs.
Highlights from the new study
- Functional screening pinpointed RBM42 as a key mediator of oncogenic mRNA translation.
- RBM42 enhances specificity in translational control, favoring cancer-related transcripts.
- Evidence suggests RBM42 helps establish a tumor-supportive proteome.
- Findings provide a mechanistic link between RBPs and selective mRNA translation in cancer.
Implications
- RBM42 may represent a novel therapeutic target for disrupting oncogenic protein synthesis.
- Highlights the broader need to map RBP-driven translation networks in oncology.
#CancerResearch#RNA#TranslationControl#Oncology#MolecularMechanisms
✨️Day4 #RNAHPI2024
On June7th, we wrapped up our final conference by discussing about #TranslationControl and #CellularStress in the context of infection.
We congratulate the winners of the best poster/flash talk/oral presentations.
@JornStok, @GaucherandLea & Edith Janssens🏆
Excited to share that I've been awarded one of the prestigious ERC Starting Grants! Big thanks to @ERC_Research for this opportunity! Time to have some fun at @CEITEC_Brno! I'm hiring at all levels, so get in touch if you're interested...
Excited to attend the @cshlmeetings on Translation Control #cshltranscon. I am presenting (yet) unpublished work on 3rd September (session 5: 10am US EDT). Looking forward to the lively discussions with the ones present at this meeting!